Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00145678 · ClinicalTrials.gov registry record · Phase 2
Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder
A Phase 2 study, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00145678 is a Phase 2 study that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 30 participants.
The verdict
NCT00145678, a Phase 2 study, has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the feasibility and effectiveness of a modified form of psychodynamic psychotherapy for persons suffering from co-occurring borderline personality disorder and an alcohol use disorder.
Interventions
- BEHAVIORAL Psychodynamic Therapy
- BEHAVIORAL Optimized Community Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-06 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00145678
The ClinicalTrials.gov registry entry for NCT00145678 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Psychodynamic Therapy is the first listed.
NCT00145678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00145678 about?
NCT00145678 is a clinical study titled "Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder". The purpose of the study is to determine the feasibility and effectiveness of a modified form of psychodynamic psychotherapy for persons suffering from co-occurring borderline personality disorder and an alcohol use disorder.
What is the current status of trial NCT00145678?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2004-06. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00145678?
The interventions under investigation include: Psychodynamic Therapy (BEHAVIORAL), Optimized Community Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT00145678?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.